The Quiet Campaign for Genetically Engineered Humans
By Richard Hayes,
Earth Island Journal, Spring 2001
| 11. 30. 2000
We are fast approaching the most consequential technological threshold in all of human history: the ability to directly manipulate the genes we pass on to our children.
Development and use of these technologies would irrevocably change the nature of human life and human society. It would destabilize human biological identity and function. It would put into play a wholly unprecedented set of social, psychological and political forces that would feed back upon themselves with impacts quite beyond our ability to imagine, much less control.
These technologies are being developed and promoted by an influential network of scientists who see themselves ushering in a new epoch for human life on Earth. They look forward to the day when parents can quite literally assemble their children from genes listed in a catalog. They celebrate a future in which our common humanity is lost as a genetically enhanced elite increasingly acquires the attributes of a separate species.
There is little public awareness of the full implications of the new human genetic engineering (HGE) technologies or of the campaign to promote them. There are...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...